We are incredibly excited to announce that Biodock has raised $2.1 million in pre-seed funding led by Andreessen Horowitz, with participation from TQ Ventures, Soma Capital, and leading angels like John Curtius, partner at Tiger Global, and Zach Weinberg, co-founder of Flatiron Health. This comes shortly after our investment from Y Combinator as part of the Winter 21 batch.

Since launching Biodock in 2020, scientists at hundreds of top research institutions like Stanford, Columbia, MIT, and Johns Hopkins have used our platform to conduct analyses on thousands of microscope images. Additionally, top pharmaceutical companies nationwide now utilize our end-to-end AI analysis platform to accelerate research on a new generation of therapeutics.

Our AI analysis platform makes research painless by managing your storage, running jobs in the cloud across powerful GPUs, and providing access through a user interface designed specifically for scientists. Best of all, our modules are up to 50% more accurate than other software solutions.

We built Biodock due to the challenges we experienced in microscopy image analysis while we were at Stanford. As a PhD student, my cofounder Nurlybek spent hours manually counting through lipid droplets in microscope images of embryonic tissues. I was working in a Stanford lab just across from his, and after chatting in a med school cafe, we realized that we were both tackling the same issues from different perspectives. This realization was the beginning of Biodock.

We're only just getting started. Biodock's goal is to accelerate analysis for all life sciences using cutting-edge AI analysis. We're incredibly excited to put this money to work to get an even better product in the hands of our users. We're growing our engineering team with hires in deep learning, infrastructure, and full stack web. Check out available positions here!